| Date Filed | Type | Description |
| 07/10/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Paid exercise price by delivering 1,430 shares
@ $29.88, valued at
$42.7k
Exercised 5,957 options to buy
@ $0 |
|
| 07/05/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 20,000 options
@ $4.11, valued at
$82.2k
|
|
| 06/30/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 12,732 options to buy
@ $31.33, valued at
$398.9k
Granted 5,985 options to buy
@ $0 |
|
| 06/28/2023 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 08/22/2022 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,100 shares
@ $0 |
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2021 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics, Inc.|
Txns:
| Granted 2,261 shares
@ $0 |
|
| 10/26/2021 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Future Health ESG Corp.|
Txns:
| Disposed/sold 1,688 shares
@ $0
Disposed/sold 1,689 shares
@ $0 |
|
| 09/16/2021 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Future Health ESG Corp.|
Txns:
| Bought 27,351 warrants
@ $1, valued at
$27.4k
|
|
| 09/09/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Bought 1,025 shares
@ $9.72, valued at
$10k
|
|
| 12/04/2020 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 11,509 options to buy
@ $18.82, valued at
$216.6k
Granted 5,578 options to buy
@ $0 |
|
| 10/29/2020 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Lyra Therapeutics, Inc.|
Txns:
| Granted 14,500 options
@ $11.76, valued at
$170.5k
|
|
| 10/29/2020 |
3
| snyderman nancy lynn MD (Director) has filed a Form 3 on Lyra Therapeutics, Inc. |
| 08/26/2020 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 3,500 shares
@ $0 |
|
| 05/22/2020 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 12,823 options to buy
@ $16.85, valued at
$216.1k
Granted 6,104 options to buy
@ $0 |
|
| 08/26/2019 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 2,083 shares
@ $0
Granted 4,167 options to buy
@ $34.1, valued at
$142.1k
|
|
| 07/01/2019 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Bought 2,000 shares
@ $37.12, valued at
$74.2k
|
|
| 05/23/2019 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 22,400 options to buy
@ $25.04, valued at
$560.9k
|
|
| 04/09/2019 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Axonics Modulation Technologies, Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $21.04, valued at
$210.4k
|
|
| 04/09/2019 |
3
| snyderman nancy lynn MD (Director) has filed a Form 3 on Axonics Modulation Technologies, Inc. |
| 05/24/2018 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 17,500 options to buy
@ $45.64, valued at
$798.7k
|
|
| 05/25/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/15/2016 |
4
| snyderman nancy lynn MD (Director) has filed a Form 4 on Alkermes plc.|
Txns:
| Granted 27,400 options to buy
@ $47.65, valued at
$1.3M
Granted 16,200 options to buy
@ $47.65, valued at
$771.9k
|
|
| 05/26/2016 |
3
| snyderman nancy lynn MD (Director) has filed a Form 3 on Alkermes plc. |